Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Multaq (dronedarone) - Important Safety Information from Sanofi-aventis as approved by the Irish Medicines Board

02 August 2011

Important Safety Information communication from Sanofi-aventis on Multaq (dronedarone) following preliminary study results showing increased cardiovascular risk.

Important Safety Information - Multaq





Date Printed: 20 June 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971